Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ceribell, Inc.CBLL · Entity 4994 | Director · President and CEO | September 15, 2026 | September 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ceribell, Inc.
Report date September 15, 2026 · Filed September 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 746,345 |
Reported balance
After 2026-09-15 transaction · row 1
1 source rowRow 1 · 2026-09-15 · Sale · Disposed 20,846 · Balance 746,345 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectBy ACP 2021 Trust | 369,088 |
Reported balance
Holding disclosure · report date 2026-09-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 369,088 F3: The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities. F4: The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
F3: The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
F4: The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 23, 2025 Filed Sep 12, 2025 16:33 UTC Amendment | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,628 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0002035784-25-000007 · ownership.xml · derivative · entry 4 Chao Xingjuan · CIK 0002035784 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 127,551 Underlying: Common Stock · 15,628 shares Expires 2029-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This Form 4/A is being filed to correct the Form 4 filed on April 24, 2025 ("Original Filing"), which inadvertently omitted reporting option exercises that occurred on April 22, 2025 and April 23, 2025, immediately prior to the respective sales reported in the Original Filing. The number of shares sold as reported in the Original Filing was correct; however, the total number of shares beneficially owned was understated due to the omission of the option exercises. As a result, the totals reported in subsequent filing were also understated. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| April 23, 2025 Filed Sep 12, 2025 16:33 UTC Amendment | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionCommon Stock | 15,628 | $2.24 | $35,006.72 |
DisclosureSEC source: 0002035784-25-000007 · ownership.xml · nonDerivative · entry 2 Chao Xingjuan · CIK 0002035784 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 768,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This Form 4/A is being filed to correct the Form 4 filed on April 24, 2025 ("Original Filing"), which inadvertently omitted reporting option exercises that occurred on April 22, 2025 and April 23, 2025, immediately prior to the respective sales reported in the Original Filing. The number of shares sold as reported in the Original Filing was correct; however, the total number of shares beneficially owned was understated due to the omission of the option exercises. As a result, the totals reported in subsequent filing were also understated. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 22, 2025 Filed Apr 24, 2025 20:47 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 300 | $15.06 | $4,518.00 |
DisclosureSEC source: 0000950170-25-058151 · ownership.xml · nonDerivative · entry 1 Chao Xingjuan · CIK 0002035784 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 742,779 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 22, 2025 Filed Sep 12, 2025 16:33 UTC Amendment | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionStock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0002035784-25-000007 · ownership.xml · derivative · entry 3 Chao Xingjuan · CIK 0002035784 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,179 Underlying: Common Stock · 300 shares Expires 2029-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This Form 4/A is being filed to correct the Form 4 filed on April 24, 2025 ("Original Filing"), which inadvertently omitted reporting option exercises that occurred on April 22, 2025 and April 23, 2025, immediately prior to the respective sales reported in the Original Filing. The number of shares sold as reported in the Original Filing was correct; however, the total number of shares beneficially owned was understated due to the omission of the option exercises. As a result, the totals reported in subsequent filing were also understated. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| April 22, 2025 Filed Sep 12, 2025 16:33 UTC Amendment | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionCommon Stock | 300 | $2.24 | $672.00 |
DisclosureSEC source: 0002035784-25-000007 · ownership.xml · nonDerivative · entry 1 Chao Xingjuan · CIK 0002035784 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 752,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This Form 4/A is being filed to correct the Form 4 filed on April 24, 2025 ("Original Filing"), which inadvertently omitted reporting option exercises that occurred on April 22, 2025 and April 23, 2025, immediately prior to the respective sales reported in the Original Filing. The number of shares sold as reported in the Original Filing was correct; however, the total number of shares beneficially owned was understated due to the omission of the option exercises. As a result, the totals reported in subsequent filing were also understated. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 21, 2025 Filed Apr 22, 2025 01:31 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 3,372 | $15.03 | $50,681.16 |
DisclosureSEC source: 0000950170-25-056445 · ownership.xml · nonDerivative · entry 2 Chao Xingjuan · CIK 0002035784 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 743,079 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 21, 2025 Filed Sep 12, 2025 16:32 UTC Amendment | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,372 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0002035784-25-000006 · ownership.xml · derivative · entry 4 Chao Xingjuan · CIK 0002035784 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,479 Underlying: Common Stock · 3,372 shares Expires 2029-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This Form 4/A is being filed to correct the Form 4 filed on April 21, 2025 ("Original Filing"), which inadvertently omitted reporting option exercises that occurred on April 17, 2025 and April 21, 2025, immediately prior to the respective sales reported in the Original Filing. The number of shares sold as reported in the Original Filing was correct; however, the total number of shares beneficially owned was understated due to the omission of the option exercises. As a result, the totals reported in subsequent filing were also understated. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| April 21, 2025 Filed Sep 12, 2025 16:32 UTC Amendment | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionCommon Stock | 3,372 | $2.24 | $7,553.28 |
DisclosureSEC source: 0002035784-25-000006 · ownership.xml · nonDerivative · entry 2 Chao Xingjuan · CIK 0002035784 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 761,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This Form 4/A is being filed to correct the Form 4 filed on April 21, 2025 ("Original Filing"), which inadvertently omitted reporting option exercises that occurred on April 17, 2025 and April 21, 2025, immediately prior to the respective sales reported in the Original Filing. The number of shares sold as reported in the Original Filing was correct; however, the total number of shares beneficially owned was understated due to the omission of the option exercises. As a result, the totals reported in subsequent filing were also understated. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 17, 2025 Filed Apr 22, 2025 01:31 UTC | Ceribell, Inc. CBLL · Entity 4994 | SaleCommon Stock | 5,700 | $15.02 | $85,614.00 |
DisclosureSEC source: 0000950170-25-056445 · ownership.xml · nonDerivative · entry 1 Chao Xingjuan · CIK 0002035784 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 746,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the range set forth in this footnote. Read SEC document |
| April 17, 2025 Filed Sep 12, 2025 16:32 UTC Amendment | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,700 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0002035784-25-000006 · ownership.xml · derivative · entry 3 Chao Xingjuan · CIK 0002035784 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,851 Underlying: Common Stock · 5,700 shares Expires 2029-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This Form 4/A is being filed to correct the Form 4 filed on April 21, 2025 ("Original Filing"), which inadvertently omitted reporting option exercises that occurred on April 17, 2025 and April 21, 2025, immediately prior to the respective sales reported in the Original Filing. The number of shares sold as reported in the Original Filing was correct; however, the total number of shares beneficially owned was understated due to the omission of the option exercises. As a result, the totals reported in subsequent filing were also understated. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · derivative.exercise_date: The stock option is fully vested and currently exercisable. Read SEC document |
| April 17, 2025 Filed Sep 12, 2025 16:32 UTC Amendment | Ceribell, Inc. CBLL · Entity 4994 | Exercise / conversionCommon Stock | 5,700 | $2.24 | $12,768.00 |
DisclosureSEC source: 0002035784-25-000006 · ownership.xml · nonDerivative · entry 1 Chao Xingjuan · CIK 0002035784 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 757,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This Form 4/A is being filed to correct the Form 4 filed on April 21, 2025 ("Original Filing"), which inadvertently omitted reporting option exercises that occurred on April 17, 2025 and April 21, 2025, immediately prior to the respective sales reported in the Original Filing. The number of shares sold as reported in the Original Filing was correct; however, the total number of shares beneficially owned was understated due to the omission of the option exercises. As a result, the totals reported in subsequent filing were also understated. F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 17:53 UTC | Ceribell, Inc. CBLL · Entity 4994 | GrantStock Option (Right to Buy) · Derivative | 151,582 | $0.00 Strike: $18.77 | $0.00 |
DisclosureSEC source: 0000950170-25-050221 · ownership.xml · derivative · entry 3 Chao Xingjuan · CIK 0002035784 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,582 Underlying: Common Stock · 151,582 shares Expires 2035-04-01 F4 · derivative.exercise_date: The shares subject to the option shall vest on each quarterly anniversary from August 20, 2025, subject to the Reporting Person's continued employment service relationship with the Issuer on each such vesting date. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 17:53 UTC | Ceribell, Inc. CBLL · Entity 4994 | GrantCommon Stock | 90,950 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-050221 · ownership.xml · nonDerivative · entry 1 Chao Xingjuan · CIK 0002035784 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 752,151 F1 · shares: Grant of restricted stock units ("RSUs"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.